These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8061453)

  • 1. MR imaging of soft-tissue masses: role of gadopentetate dimeglumine.
    Benedikt RA; Jelinek JS; Kransdorf MJ; Moser RP; Berrey BH
    J Magn Reson Imaging; 1994; 4(3):485-90. PubMed ID: 8061453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate.
    Ros PR; Gauger J; Stoupis C; Burton SS; Mao J; Wilcox C; Rosenberg EB; Briggs RW
    AJR Am J Roentgenol; 1995 Dec; 165(6):1447-51. PubMed ID: 7484583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of gadopentetate dimeglumine-enhanced, high-resolution magnetic resonance imaging to differentiate among melanin-containing skin tumors.
    Mäurer J; Schlums D; Knollmann FD; Garbe C; Vogl TJ; Bier J; Felix R
    Acad Radiol; 1996 Mar; 3(3):186-91. PubMed ID: 8796663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients.
    Vogl TJ; Mack MG; Juergens M; Stark M; Pegios W; Bergman C; Grevers G; Western A
    AJR Am J Roentgenol; 1994 Aug; 163(2):425-32. PubMed ID: 8037044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
    Kopka L; Funke M; Fischer U; Keating D; Oestmann J; Grabbe E
    AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the rate of gadopentetate dimeglumine administration on abdominal vascular and soft-tissue MR imaging enhancement patterns.
    Strouse PJ; Prince MR; Chenevert TL
    Radiology; 1996 Dec; 201(3):809-16. PubMed ID: 8939236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of fat-suppression technique and gadopentetate dimeglumine in magnetic resonance imaging evaluation of intraocular tumors and simulating lesions.
    De Potter P; Flanders AE; Shields JA; Shields CL; Gonzales CF; Rao VM
    Arch Ophthalmol; 1994 Mar; 112(3):340-8. PubMed ID: 8129659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions.
    Mahfouz AE; Hamm B; Wolf KJ
    Radiology; 1994 Jan; 190(1):49-52. PubMed ID: 8259426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it necessary to routinely use gadolinium in the MR imaging evaluation of soft-tissue tumors of the extremities?
    Kransdorf MJ
    AJR Am J Roentgenol; 1995 Dec; 165(6):1545. PubMed ID: 7484606
    [No Abstract]   [Full Text] [Related]  

  • 10. Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging--parametric "first-pass" images depict tissue vascularization and perfusion.
    Verstraete KL; De Deene Y; Roels H; Dierick A; Uyttendaele D; Kunnen M
    Radiology; 1994 Sep; 192(3):835-43. PubMed ID: 8058957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions.
    Hawighorst H; Knapstein PG; Schaeffer U; Knopp MV; Brix G; Hoffmann U; Zuna I; Essig M; van Kaick G
    AJR Am J Roentgenol; 1996 Feb; 166(2):401-8. PubMed ID: 8553955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography.
    Gribbestad IS; Nilsen G; Fjøsne HE; Kvinnsland S; Haugen OA; Rinck PA
    J Magn Reson Imaging; 1994; 4(3):477-80. PubMed ID: 8061451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
    Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
    Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative evaluation for intracranial recurrence of medulloblastoma: MR findings with gadopentetate dimeglumine.
    Meyers SP; Wildenhain S; Chess MA; Tarr RW
    AJNR Am J Neuroradiol; 1994 Sep; 15(8):1425-34. PubMed ID: 7985559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign and malignant musculoskeletal masses: MR imaging differentiation with rim-to-center differential enhancement ratios.
    Ma LD; Frassica FJ; McCarthy EF; Bluemke DA; Zerhouni EA
    Radiology; 1997 Mar; 202(3):739-44. PubMed ID: 9051028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of gadopentetate dimeglumine for 1.5-T MR imaging of musculoskeletal masses: comparison with unenhanced T1- and T2-weighted imaging.
    Rosenthal RE; Wozney P
    J Magn Reson Imaging; 1991; 1(5):547-51. PubMed ID: 1790379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine.
    Pediconi F; Catalano C; Occhiato R; Venditti F; Fraioli F; Napoli A; Kirchin MA; Passariello R
    Radiology; 2005 Oct; 237(1):45-56. PubMed ID: 16126926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spleen: dynamic enhancement patterns on gradient-echo MR images enhanced with gadopentetate dimeglumine.
    Semelka RC; Shoenut JP; Lawrence PH; Greenberg HM; Madden TP; Kroeker MA
    Radiology; 1992 Nov; 185(2):479-82. PubMed ID: 1410358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging of spondylitis with gadopentetate dimeglumine enhancement.
    Demaerel P; van Ongeval C; Wilms G; Lateur L; Baert AL
    J Neuroradiol; 1994 Dec; 21(4):245-54. PubMed ID: 7884486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine.
    Pediconi F; Catalano C; Padula S; Roselli A; Dominelli V; Cagioli S; Kirchin MA; Pirovano G; Passariello R
    AJR Am J Roentgenol; 2008 Nov; 191(5):1339-46. PubMed ID: 18941066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.